Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Ipca Laboratories Ltd spurts 0.16%, up for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1627.6, up 0.16% on the day as on 12:44 IST on the NSE. The stock is up 19.88% in last one year as compared to a 4.96% jump in NIFTY and a 15.12% jump in the Nifty Pharma.
Ipca Laboratories Ltd eases for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1575.6, down 0.47% on the day as on 13:19 IST on the NSE. The stock tumbled 15.63% in last one year as compared to a 4.2% slide in NIFTY and a 9.97% fall in the Nifty Pharma index.
Ipca Labs ties up with biotech firm to develop cancer and autoimmune disease treatments
Ipca Laboratories has signed a global licensing deal with BRL to develop and commercialise biologic therapies for cancer and autoimmune diseases.
Unichem may finally start paying off for Ipca Laboratories
Ipca stock’s valuation seem reasonable relative to its earnings potential over the next few years. They trade at around 30 times its FY27 estimated earnings
Ipca Laboratories Ltd soars 0.79%, rises for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1654.8, up 0.79% on the day as on 12:44 IST on the NSE. The stock is up 20.85% in last one year as compared to a 7.43% spurt in NIFTY and a 11.54% spurt in the Nifty Pharma.
Ipca Laboratories Ltd gains for third straight session
Ipca Laboratories Ltd is quoting at Rs 1598.7, up 2.83% on the day as on 12:49 IST on the NSE. The stock is up 15.35% in last one year as compared to a 5.46% jump in NIFTY and a 11.8% jump in the Nifty Pharma index.
Ipca Laboratories among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish momentum as their RSI crossed above 50, signaling potential upward price movement.
Ipca Labs Q4 aided by strong India business, export growth; ₹6 dividend declared
Ipca Laboratories reported healthy fourth-quarter growth in revenue and operating profit, supported by strong performance in domestic formulations and exports, while margins improved year-on-year on better operational performance.
Q4 Results On May 29: Asian Paints, BEML, IndiGo, Glenmark Pharma, NMDC Among Over 700 Companies To Share Earnings
Inox Wind, Ipca Laboratories, Aegis Logistics, Olectra Greentech and Mishra Dhatu Nigam are among the other names that will announce Q4FY26 results on Friday.
Raja Venkatraman, MarketSmith recommend five stocks for 20 March
On March 19, Nifty 50 and Sensex dropped over 3% due to HDFC Bank chairman's resignation and rising crude oil prices. Analysts recommend buying Ipca Laboratories, Great Eastern Shipping, Colgate Palmolive, Glenmark Pharmaceuticals, and Power Finance Corporation amid market volatility.
Jindal Poly among 4 stocks that hit 52-week highs & rallied up to 95% in a month
The Sensex surged 568 points to close at 76,070 on Tuesday, driving a broader market rally. Four BSE 1000 stocks—Jindal Poly Films, Acutaas Chemicals, Vardhman Textiles and Ipca Laboratories—hit 52-week highs, signaling bullish momentum and potential gains ahead.
Buy Ipca Laboratories; target of Rs 1800: Emkay Global Financial
Emkay Global Financial is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated June 02, 2026.